Publikasi Scopus Covid-19 Per 15 Juni 2023 (346 artikel)

Harbuwono, Dante S. (36056341600); Handayani, Dwi O.T.L. (57222543502); Wahyuningsih, Endang S. (57372295000); Supraptowati, Novita (57372295100); Ananda (57372140300); Kurniawan, Farid (57202309006); Wafa, Syahidatul (57208422885); Kristanti, Melly (5720
Harbuwono D.S.; Handayani D.O.T.L.; Wahyuningsih E.S.; Supraptowati N.; Ananda; Kurniawan F.; Wafa S.; Kristanti M.; Pantoro N.I.; Sinto R.; Kurniawan H.; Rebekka; Tahapary D.L.
Impact of diabetes mellitus on COVID-19 clinical symptoms and mortality: Jakarta's COVID-19 epidemiological registry
Primary Care Diabetes
Background and aims: While the higher prevalence of diabetes mellitus (DM) at younger age in Indonesia might contribute to the relatively higher COVID-19 mortality rate in Indonesia, there were currently no available evidence nor specific policy in terms
Clinical symptoms; COVID-19; Diabetes mellitus; Indonesia; Mortality
D.S. Harbuwono; Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; email: This email address is being protected from spambots. You need JavaScript enabled to view it.
Elsevier Ltd
17519918
34857490
Prim. Care Diabetes
Harbuwono D.S., Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia, Metabolic, Cardiovascular, and Aging C
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; Metabolic, Cardiovascular, and Aging Cluster, The Indo
36056341600; 57222543502; 57372295000; 57372295100; 57372140300; 57202309006; 57208422885; 57208222835; 57372295200; 36099377100; 57371988700; 57371988800; 55944492500
6
2022
Article